For CD33 (Siglec-3), we demonstrate that it recognizes both α2-3 and α2-6 sialosides in solution and on cells, which has implications for its link to Alzheimer’s disease susceptibility. This evidence concerns the gene CD33 and early-onset autosomal dominant Alzheimer disease.